Adial Pharmaceuticals
ADIL
$1.50
Share price
-9.09%
Change (1 day)
400.00%
Change (1 year)
Categories
Adial Pharmaceuticals (ADIL) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.52 M
According to Adial Pharmaceuticals 's latest financial reports the company's total liabilities are $0.52 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Adial Pharmaceuticals - Total liabilities on balance sheet (from 2016 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $2.45 M | -38.08% |
| 2021-12-31 | $3.96 M | 163.53% |
| 2020-12-31 | $1.5 M | 179.26% |
| 2019-12-31 | $0.53 M | 108.96% |
| 2018-12-31 | $0.25 M | -75% |
| 2017-12-31 | $1.03 M | 304.71% |
| 2016-12-31 | $0.25 M | 380.44% |
| 2015-12-31 | $0.05 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | 496.01% | Bahamas |
 NRC Health
NRC | $73.48 M | 13,812.33% | 🇺🇸 USA |